Why BriaCell Therapeutics (BCTX) Stock Is Down 40%
Why BriaCell Therapeutics (BCTX) Stock Is Down 40%
The offering, managed by BriaCell Therapeutics Corp (NASDAQ:BCTX) shares are trading lower by 40% to 65 cents Thursday afternoon after the company announced the pricing of a $5.5 million public offering of 7.4 million shares at 75 cents per share.
BriaCell Therapeutics Corp (纳斯达克:BCTX)的股票在周四下午交易下跌40%，跌至65美分，原因是该公司宣布以每股75美分的价格，进行740万股的550万美元公开发行。
What Else: BriaCell has priced an underwritten public offering of 7.4 million common shares and warrants at 75 cents per share and associated warrant.
其他消息：BriaCell已以每股75美分的价格，为740万普通股和Warrants定价，连同相关的Warrants。
The warrants, exercisable at $0.9375 per share for five years, accompany the shares in the offering, which is expected to generate gross proceeds of approximately $5.55 million before expenses.
这些Warrants的行使价为每股0.9375美元，有效期为五年，将与公开发行的股票共同进行，预计在扣除费用前将产生约555万美元的毛收入。
The offering, managed by ThinkEquity, is set to close on December 13, pending customary conditions. BriaCell says the company plans to use the funds for working capital, corporate purposes and advancing its business goals.
此次由ThinkEquity管理的公开发行计划于12月13日结束，需满足惯例条件。BriaCell表示，公司计划将这些资金用于流动资本、公司用途以及推进其业务目标。
Read Also: Stocks Fall As Producer Inflation Spikes, Jobless Claims Jump: 'What Is Happening Here?'
另见：股票下跌，生产者通胀激增，失业申请激增：‘这里发生了什么？’
According to data from Benzinga Pro, BCTX has a 52-week high of $5.93 and a 52-week low of $0.46.
根据Benzinga Pro的数据，BCTX的52周最高价为5.93美元，52周最低价为0.46美元。